BRUSSELS, April 9 (Reuters) - Pharmaceutical group Fagron said sales growth in the first quarter slowed slightly from the second half of last year, but maintained its full-year outlook.
The company, which makes ingredients for pharmacists to make bespoke medicines, said sales in the first quarter increased by 29.8 percent from last year to 117.8 million euros ($126.92 million).
06:04 Los Angeles Angels OF Kole Calhoun gets 3-year extension13
23:10 Tim Raines, Jeff Bagwell, Pudge Rodriguez elected to Baseball Hall of Fame16
21:52 Netflix nears 94 million subscribers 10 years after streaming launch13
11:20 PE firm Warburg buys $121 million stake in Indian cinema operator PVR13